A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure

Abstract

Vesnarinone is associated with a dose-dependent increase in mortality among patients with severe heart failure, an increase that is probably related to an increase in deaths due to arrhythmia. A short-term benefit in terms of the quality of life raises issues about the appropriate therapeutic goal in treating heart failure.